Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis

C Cho; M Hsu; P Barba; M A Maloy; S T Avecilla; J N Barker; H Castro-Malaspina; S A Giralt; A A Jakubowski; G Koehne; R C Meagher; R J O’Reilly; E B Papadopoulos; D M Ponce; R Tamari; M R M van den Brink; J W Young; S M Devlin; M-A Perales

doi:10.1038/bmt.2017.197

Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis

C Cho, M Hsu, P Barba, M A Maloy, S T Avecilla, J N Barker, H Castro-Malaspina, S A Giralt, A A Jakubowski, G Koehne, R C Meagher, R J O’Reilly, E B Papadopoulos, D M Ponce, R Tamari, M R M van den Brink, J W Young, S M Devlin, M-A Perales

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Bone marrow transplantation
Volume	52
DOIs	https://doi.org/10.1038/bmt.2017.197
State	Published - Jan 12 2017

Disciplines

Medicine and Health Sciences
Immunology and Infectious Disease

Access to Document

10.1038/bmt.2017.197License: Unspecified

Cite this

Cho, C., Hsu, M., Barba, P., Maloy, M. A., Avecilla, S. T., Barker, J. N., Castro-Malaspina, H., Giralt, S. A., Jakubowski, A. A., Koehne, G., Meagher, R. C., O’Reilly, R. J., Papadopoulos, E. B., Ponce, D. M., Tamari, R., van den Brink, M. R. M., Young, J. W., Devlin, S. M., & Perales, M.-A. (2017). Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis. Bone marrow transplantation, 52. https://doi.org/10.1038/bmt.2017.197

Cho, C, Hsu, M, Barba, P, Maloy, MA, Avecilla, ST, Barker, JN, Castro-Malaspina, H, Giralt, SA, Jakubowski, AA, Koehne, G, Meagher, RC, O’Reilly, RJ, Papadopoulos, EB, Ponce, DM, Tamari, R, van den Brink, MRM, Young, JW, Devlin, SM & Perales, M-A 2017, 'Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis', Bone marrow transplantation, vol. 52. https://doi.org/10.1038/bmt.2017.197

@article{e444b028fb994aef8926d1a3385f69a6,

title = "Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis",

author = "C Cho and M Hsu and P Barba and Maloy, \{M A\} and Avecilla, \{S T\} and Barker, \{J N\} and H Castro-Malaspina and Giralt, \{S A\} and Jakubowski, \{A A\} and G Koehne and Meagher, \{R C\} and O{\textquoteright}Reilly, \{R J\} and Papadopoulos, \{E B\} and Ponce, \{D M\} and R Tamari and \{van den Brink\}, \{M R M\} and Young, \{J W\} and Devlin, \{S M\} and M-A Perales",

note = "Altmetric: 3 More detail Original Article Graft Manipulation Bone Marrow Transplantation 52, 1629-1636 (2017) doi:10.1038/bmt.2017.197 Download Citation Received: Revised: Accepted: Published online: CD34+ cell selection significantly improves GvHD-free survival in allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, specific information regarding long-term prognosis and risk factors for late mortality after CD34+ cell-selected allo-HSCT is lacking.",

year = "2017",

month = jan,

day = "12",

doi = "10.1038/bmt.2017.197",

language = "American English",

volume = "52",

journal = "Bone marrow transplantation",

}

TY - JOUR

T1 - Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis

AU - Cho, C

AU - Hsu, M

AU - Barba, P

AU - Maloy, M A

AU - Avecilla, S T

AU - Barker, J N

AU - Castro-Malaspina, H

AU - Giralt, S A

AU - Jakubowski, A A

AU - Koehne, G

AU - Meagher, R C

AU - O’Reilly, R J

AU - Papadopoulos, E B

AU - Ponce, D M

AU - Tamari, R

AU - van den Brink, M R M

AU - Young, J W

AU - Devlin, S M

AU - Perales, M-A

N1 - Altmetric: 3 More detail Original Article Graft Manipulation Bone Marrow Transplantation 52, 1629-1636 (2017) doi:10.1038/bmt.2017.197 Download Citation Received: Revised: Accepted: Published online: CD34+ cell selection significantly improves GvHD-free survival in allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, specific information regarding long-term prognosis and risk factors for late mortality after CD34+ cell-selected allo-HSCT is lacking.

PY - 2017/1/12

Y1 - 2017/1/12

UR - http://www.nature.com/bmt/journal/v52/n12/abs/bmt2017197a.html

U2 - 10.1038/bmt.2017.197

DO - 10.1038/bmt.2017.197

M3 - Article

VL - 52

JO - Bone marrow transplantation

JF - Bone marrow transplantation

ER -

Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis

Disciplines

Access to Document

Other files and links

Cite this